Recurrent malignant hyperthermia after scoliosis correction surgery
Junfeng Su, Man Huang
Table 1. Patient's condition after operation
Date (after operation) Shivering frequency Tmax (℃) ETCO2max
(mmHg)
CKmax Sedation Respiratory support Dantrolene usage Dantrolene dose (mg)
D0 (ICU admission) No shivering 37.1 45 1,591 Propofol+remifentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 100%, PEEP: 5 cmH2O, SpO2 ≥94% 40 mg iv. Q6h (1 iv) 40
D1 5 times, continued for 1 min per time 37.7 43 6,450 Propofol+remifentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 5 cmH2O, SpO2 ≥94% 40 mg iv. Q6h (4 iv) & 40 mg bolus 200
D2 5 times, continued for 1 min, 1 min, 2 min, 1 min, and 10 min, respectively 39.5 54 8,310 Midazolam+remifentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 5 cmH2O, SpO2 ≥94% 40 mg iv. Q6h (4 iv) 160
D3 2 times, continued for 10 min, and 30 min, respectively 38.5 56 8,060 Midazolam+remifentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 8 cmH2O, SpO2 ≥94% 40 mg bolus (2 iv) & 40 mg iv. Q6h (3 iv) 200
D4 4 times, continued for 30 min, 30 min, 30 min, and 50 min, respectively 38.0 58 4,210 Propofol+midazolam+remifentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 8 cmH2O, SpO2 ≥94% 60 mg iv. Q6h (4 iv) & 60 mg bolus 300
D5 1 time, continued for 15 min 38.8 55 3,500 Propofol+midazolam+sufentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 8 cmH2O, SpO2 ≥94% 60 mg iv. Q6h (4 iv) 240
D6 4 times, continued for 5 min, 6 min, 5 min, and 5 min, respectively 38.6 51 2,700 Propofol+midazolam+sufentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 8 cmH2O, SpO2 ≥94% 60 mg iv. Q6h (3 iv) & iv.vp. 10 mg/h for 3 h 210
D7 5 times, continued for 7 min, 20 min, 10 min, 10 min, and 12 min respectively 38.9 56 2,700 Propofol+midazolam+sufentanil
RASS score: -4 to -2
Mechanical ventilation with FiO2: 40%, PEEP: 8 cmH2O, SpO2 ≥94% iv.vp. 10 mg/h for 7 h & 60 mg iv. Q6h (4 iv) 310
D8 3 times, continued for 12 min, 6 min, and 8 min, respectively 38.0 53 12,330 Desist from sedation Removal of endotracheal intubation & high-flow oxygen therapy (flow rate 35 L/min, oxygen concentration 40%, SpO2 ≥94%) 60 mg iv. Q6h (4 iv) 240
D9 Persistent weak shivering for 120 min 39.3 - 12,800 - High-flow oxygen therapy (flow rate 35L/min, oxygen concentration 50%-100%, SpO2 ≥94%) 60 mg iv. Q6h (4 iv) 240
D10 Shivering for 10 min, persistent weak shivering for hours 38.9 - 8,020 - Sat beside the bed (for rehabilitation exercise) for 30 min in the late morning with nasal catheter oxygen inhalation 5 L /min, SpO2 91%-95%, and continued to tremble in the afternoon, then high-flow oxygen therapy (flow rate 25 L/min, oxygen concentration 50%-55%, SpO2 ≥94%) 60 mg iv. Q6h (2 iv) & 40 mg iv. Q6h (2 iv) 200
D11 No shivering 37.7 - 3,700 - Nasal catheter oxygen inhalation 5 L /min, SPO2 ≥94% 60 mg bolus & 40 mg bolus then stop dosing 100
D12 No shivering 37.3 - - - Nasal catheter oxygen inhalation 5 L/min, SpO2 ≥94% - 0
D13 No shivering 36.9 - - - Nasal catheter oxygen inhalation 5 L/min, SpO2 ≥94% - 0
D14 (left ICU) Weak shivering (head and limbs) improved automatically in a few minutes 37.4 - - - Nasal catheter oxygen inhalation 5 L/min, SpO2 ≥94%
Transfered to orthopedic ward
- 0
D15-D35 No shivering <37.5 - D15 (920) D19 (645) Nasal catheter oxygen inhalation 3 L/min, SpO2 ≥94% (D15); no oxygen inhalation (D16-D35) - 0